Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia

European Journal of Anaesthesiology

Volumn 21, Issue 10, 2004, Pages 781-786

  Maidatsi, Panagiota G ^a   Zaralidou, A Th ^a   Gorgias, N K ^b   Amaniti, E N ^a   Karakoulas, K A ^a   Giala, M M ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b Saint Demetrios General Hospital   (Greece)

Author keywords

Anaesthetics inhalation, sevoflurane, desflurane; Anaesthetics intravenous, propofol; Neuromuscular blocking agents, rocuronium, monitoring, duration of action

Indexed keywords

DESFLURANE; FENTANYL; INHALATION ANESTHETIC AGENT; MORPHINE; MUSCLE RELAXANT AGENT; PROPOFOL; ROCURONIUM; SEVOFLURANE; THIOPENTAL;

ABDOMINAL SURGERY; ACCELEROMETER; ADDUCTOR POLLICIS MUSCLE; ADULT; ANALYSIS OF VARIANCE; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; DRUG POTENTIATION; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; EVALUATION; FEMALE; HAND MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE TWITCH; NERVE STIMULATION; NEUROMUSCULAR FUNCTION; PATIENT MONITORING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; ULNAR NERVE;

ABDOMEN; ADULT; ANDROSTANOLS; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; ISOFLURANE; MALE; METHYL ETHERS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPOFOL; TIME FACTORS;

EID: 14244260865     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-200410000-00005     Document Type: Article

References (17)

1. Wright PM, Hart P, Lau M, et al. The magnitude and time course of vecuronium by desflurane versus isoflurane. Anesthesiology 1995; 82: 404-411.
2. Wulf H, Hauschild S, Proppe D, Ledowski T. Augmentation of the neuromuscular blocking effect of mivacurium during inhalation anesthesia with desflurane, sevoflurane and isoflurane in comparison with total intravenous anesthesia. Anaesthesiol Reanim 1998; 23: 88-92.
3. Wulf H, Kahl M, Ledowski T. Neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia. Br J Anaesth 1998; 80: 308-312.
4. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84: 43-47.
5. Wulf H, Ledowski T, Linstedt U, Proppe D, Sitzlack D. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane and sevoflurane anaesthesia. Can J Anaesth 1998; 45: 526-532.
6. Rampil IJ, Stephen HL, Zwass MS, Peterson N, et al. Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 1991; 74: 429-433.
7. Fragen RJ, Dunn KL. The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. J Clin Anesth 1996; 8: 352-356.
8. Meretoja OA, Wirtavuori K, Taivainen T, Olkkola KT. Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 1996; 76: 235-238.
9. Ahmed AA, Kumagai M, Otake T, Kurata Y, Amaki Y. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium. Can J Anaesth 1999; 46: 429-432.
10. Yasuda N, Targ AG, Eger EI. Solubility of 1-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69: 370-373.
11. Kumar N, Mirakhur R, Symington MJJ, McCarthy GJ. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia. Br J Anaesth 1996; 77: 488-491.
12. Lowry DW, Mirakhur R, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anesthesia. Anesth Analg 1998; 87: 936-940.
13. Meistelman C, Plaud B, Donati F. Rocuronium (Org 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth 1992; 39: 665-669.
14. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991; 74: 833-837.
15. Amaniti E, Maidatsi P, Zaralidou A, Giala M. Variations in the duration of action of two aminosteroid neuromuscular blocking agents. Eur J Anaesth 2001; 18 (Suppl 21): A-502 [Abstract].
16. Van den Broek L, Wierda JMKH, Smeulers NJ, et al. Clinical pharmacology of rocuronium (Org 9426); study on the time course of action, dose requirement, reversibility and pharmacokinetics. J Clin Anesth 1994; 6: 288-296.
17. Dragne A, Varin F, Plaud B, Donati F. Rocuronium pharmacokinetic- pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anesth 2002; 49: 353-360.